Press Release

NeoGenomics Reports Third Quarter 2022 Results

NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

NeoGenomics Lab Operations | Hurricane Ian Update

NeoGenomics Hurricane Ian Emergency Response

NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients